Stockreport

Blueprint Medicines advancing lead candidate avapritinib, sets two-year plan; shares up 3% [Seeking Alpha]

Blueprint Medicines Corporation  (BPMC) 
Last blueprint medicines corporation earnings: 2/13 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: blueprintmedicines.com
PDF Blueprint Medicines advancing lead candidate avapritinib, sets two-year plan; shares up 3% [Read more]